Canvas Wealth Advisors LLC Boosts Holdings in The Clorox Company $CLX

Canvas Wealth Advisors LLC boosted its position in shares of The Clorox Company (NYSE:CLX) by 190.5% in the second quarter, HoldingsChannel reports. The fund owned 29,548 shares of the company’s stock after purchasing an additional 19,377 shares during the quarter. Clorox makes up 0.8% of Canvas Wealth Advisors LLC’s portfolio, making the stock its 29th largest position. Canvas Wealth Advisors LLC’s holdings in Clorox were worth $3,760,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently bought and sold shares of the company. Stephens Inc. AR lifted its position in Clorox by 32.4% during the second quarter. Stephens Inc. AR now owns 3,778 shares of the company’s stock valued at $454,000 after acquiring an additional 924 shares during the last quarter. Chicago Partners Investment Group LLC lifted its position in Clorox by 29.7% during the second quarter. Chicago Partners Investment Group LLC now owns 2,514 shares of the company’s stock valued at $330,000 after acquiring an additional 575 shares during the last quarter. MB Levis & Associates LLC lifted its position in Clorox by 3.3% during the second quarter. MB Levis & Associates LLC now owns 6,095 shares of the company’s stock valued at $732,000 after acquiring an additional 194 shares during the last quarter. VIRGINIA RETIREMENT SYSTEMS ET Al purchased a new stake in Clorox during the second quarter valued at approximately $216,000. Finally, Chevy Chase Trust Holdings LLC lifted its position in Clorox by 0.9% during the second quarter. Chevy Chase Trust Holdings LLC now owns 88,212 shares of the company’s stock valued at $10,592,000 after acquiring an additional 790 shares during the last quarter. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Clorox Stock Up 1.8%

NYSE:CLX opened at $119.73 on Monday. The company has a debt-to-equity ratio of 5.15, a current ratio of 0.84 and a quick ratio of 0.57. The company’s fifty day moving average price is $121.61 and its 200-day moving average price is $127.58. The Clorox Company has a 1-year low of $116.53 and a 1-year high of $171.37. The firm has a market capitalization of $14.58 billion, a P/E ratio of 18.36, a PEG ratio of 0.99 and a beta of 0.52.

Clorox (NYSE:CLX) last issued its earnings results on Thursday, July 31st. The company reported $2.87 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.24 by $0.63. Clorox had a net margin of 11.40% and a return on equity of 377.86%. The firm had revenue of $1.99 billion during the quarter, compared to analysts’ expectations of $1.94 billion. During the same quarter last year, the company posted $1.82 earnings per share. The firm’s revenue was up 4.5% compared to the same quarter last year. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. As a group, equities research analysts anticipate that The Clorox Company will post 7.15 EPS for the current year.

Clorox Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, November 6th. Investors of record on Wednesday, October 22nd will be issued a dividend of $1.24 per share. This represents a $4.96 annualized dividend and a dividend yield of 4.1%. The ex-dividend date of this dividend is Wednesday, October 22nd. Clorox’s dividend payout ratio (DPR) is 76.07%.

Insider Activity

In related news, COO Eric H. Reynolds sold 15,041 shares of the firm’s stock in a transaction on Thursday, September 4th. The shares were sold at an average price of $123.78, for a total transaction of $1,861,774.98. Following the completion of the transaction, the chief operating officer owned 54,221 shares of the company’s stock, valued at $6,711,475.38. This trade represents a 21.72% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. 0.63% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

A number of research firms recently commented on CLX. Bank of America decreased their target price on shares of Clorox from $135.00 to $125.00 and set a “neutral” rating for the company in a research report on Wednesday, October 8th. BNP Paribas Exane decreased their price target on shares of Clorox from $118.00 to $110.00 and set an “underperform” rating for the company in a report on Friday. Citigroup decreased their price target on shares of Clorox from $135.00 to $130.00 and set a “neutral” rating for the company in a report on Wednesday, October 8th. TD Cowen decreased their price target on shares of Clorox from $120.00 to $117.00 and set a “hold” rating for the company in a report on Wednesday, October 1st. Finally, Barclays decreased their price target on shares of Clorox from $118.00 to $112.00 and set an “underweight” rating for the company in a report on Tuesday, September 30th. One analyst has rated the stock with a Buy rating, twelve have assigned a Hold rating and four have assigned a Sell rating to the company. Based on data from MarketBeat.com, Clorox has a consensus rating of “Reduce” and a consensus target price of $130.20.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.